Impact of cemiplimab treatment duration on clinical outcomes in advanced cutaneous squamous cell carcinoma.
Mallardo D, Sparano F, Vitale MG, Trojaniello C, Fordellone M, Cioli E, Esposito A, Festino L, Mallardo M, Vanella V, Facchini BA, De Filippi R, Meinardi P, Ottaviano M, Caracò C, Simeone E, Ascierto PA.
Mallardo D, et al. Among authors: de filippi r.
Cancer Immunol Immunother. 2024 Jun 8;73(8):160. doi: 10.1007/s00262-024-03728-z.
Cancer Immunol Immunother. 2024.
PMID: 38850335
Free PMC article.